News Release

Full Year Financial Highlights

• Read volume up 21% to 2.7 million
• Revenue up 13% to $120.7 million
• Adjusted EBITDA⁽¹⁾ up 34% to $27.6 million and 23% of revenue
• Adjusted net income⁽²⁾ up 31% to $12.7 million; adjusted diluted earnings per share⁽³⁾ (EPS) up 37% to $0.78
• GAAP net income of $7.9 million; GAAP diluted EPS of $0.48
• Cash of $50.2 million, up from cash and short-term investments of $29.3 million at December 31, 2008; the Company has no debt

Fourth Quarter Financial Highlights

• Read volume up 16% to 687,000
• Revenue up 6% to $29.9 million
• Adjusted EBITDA⁽¹⁾ up 16% to $5.8 million and 19% of revenue
• Adjusted net income⁽²⁾ up 18% to $2.4 million; adjusted diluted earnings per share⁽³⁾ (EPS) up 25% to $0.15
• GAAP net income of $1.1 million; GAAP diluted EPS of $0.07

Additional Fourth Quarter Highlights

• Finals volume grew 47%, representing 32% of total volume
• Ranked #1 in Teleradiology Services by KLAS for second consecutive year
• Released vRad Enterprise Connect 2.1, providing radiology practices with added productivity and growth tools
• Named to Deloitte's 2009 Technology Fast 500(TM)
• Completed deployment of proprietary vRad PACS to all of its 143 affiliated radiologists

"We are pleased with our full year financial performance despite the challenging economic environment that existed throughout 2009," said Rob Kill, Virtual Radiologic's president and chief executive officer. "We believe we have positioned Virtual Radiologic to continue as the innovative growth leader in the virtual radiology arena."

Fourth Quarter and Full Year Results

Total revenue increased 6% to $29.9 million and 13% to $120.7 million for the three and twelve months ended December 31, 2009, compared to $28.3 million and $106.6 million for the three and twelve months ended December 31, 2008. The increase in revenue over the fourth quarter and full year of 2008 resulted primarily from a 14% year-over-year increase in the number of hospitals and medical facilities served to 1,173 as of December 31, 2009, representing approximately 19% of all hospitals in the United States.

Adjusted EBITDAincreased 16% to $5.8 million and 34% to $27.6 million for the three and twelve months ended December 31, 2009, compared to $5.0 million and $20.5 million for the three and twelve months ended December 31, 2008. Adjusted EBITDA was 19% and 23% of revenue for the three and twelve months ended December 31, 2009 compared to 18% and 19% for the prior year periods.

Adjusted net incomeincreased 18% to $2.4 million and 31% to $12.7 million for the three and twelve months ended December 31, 2009, compared to $2.0 million and $9.7 million for the three and twelve months ended December 31, 2008. This resulted in an adjusted diluted EPS of $0.15 and $0.78 for the three and twelve months ended December 31, 2009, compared to $0.12 and $0.57 for the three and twelve months ended December 31, 2008.

GAAP net income was $1.1 million and $7.9 million for the three and twelve months ended December 31, 2009, compared to $890,000 and $8.5 million for the three and twelve months ended December 31, 2008, resulting in diluted earnings per share of $0.07 and $0.48 for the three and twelve months ended December 31, 2009, compared to $0.05 and $0.50 for the three and twelve months ended December 31, 2008, respectively.

2010 Guidance

The Company is providing the following guidance for the full year of 2010:

• Revenue ranging from $127.0 million to $131.0 million
• Adjusted EBITDA ranging from $28.0 million to $30.0 million
• Adjusted net income ranging from $12.6 million to $13.8 million
• Adjusted diluted earnings per share ranging from $0.75 to $0.82

Conference Call Information

The Company will be hosting a conference call January 25, 2010 at 4:30 p.m. Eastern Time to discuss these results and provide a general business update. Participants can access the call by dialing (800) 561-2693 (within the United States and Canada), or (617) 614-3523 (outside the United States and Canada), using passcode 78354286. A live webcast of the conference call will be available on the Company's corporate web site at http://ir.virtualrad.com under "Calendar of Events." A replay of the call will be available from 7:30 p.m. Eastern Time on Monday, January 25, 2010, through midnight on Monday, February 1, 2010. Access the replay by dialing (888) 286-8010 or (617) 801-6888, using passcode 62331925.

About Virtual Radiologic

Virtual Radiologic Corporation (vRad) is a national radiology practice working in partnership with radiologists and hospitals to optimize radiology's pivotal role in the delivery of patient care. Enabled by next-generation technology, vRad's collaborative partnerships enhance productivity and deliver demonstrated quality outcomes that help lower the overall cost of care. vRad's 143 affiliated radiologists serve 1,170 facilities (nearly 20% of U.S. hospitals), reading more than 2.6 million interpretations annually with unparalleled subspecialist expertise and expedited time to diagnosis. Continually recognized for high-quality reports and industry-leading service, vRad is ranked #1 in the teleradiology services category by independent healthcare research firm KLAS and has received the Joint Commission Gold Seal of Approval each year since 2004. For more information, visit www.vrad.com.

Safe Harbor for Forward-Looking and Cautionary Statements

Certain statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including, in particular, statements about plans, objectives, strategies and prospects regarding, among other things, vRad's business and results of operations. These statements can be identified by the use of words such as "will," "believe," "expect," and "anticipate" and similar terms or expressions of future expectation. These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance or achievements of vRad to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. For examples of such risks and uncertainties, please see vRad's Annual Report on Form 10-K, as well as other filings with the Securities and Exchange Commission. vRad undertakes no duty to update these forward-looking statements due to new information or as a result of future events.

Notes Regarding the Use of Non-GAAP Financial Measures

vRad records its results of operations in accordance with accounting principles generally accepted in the United States of America ("GAAP"). In addition, vRad is providing certain supplemental non-GAAP information which the Company believes to be an important indicator of its financial performance. vRad uses the following non-GAAP financial measures:

• Adjusted EBITDA - net income excluding the net effects of interest, income taxes, depreciation and amortization, non-cash stock-based compensation expense and medical malpractice loss reserves (other than specific case reserves);
• Adjusted net income - net income excluding the effects of non-cash stock-based compensation, net of tax, and medical malpractice loss reserves (other than specific case reserves), net of tax; and
• Adjusted diluted earnings per share - adjusted net income divided by weighted average diluted shares outstanding.

vRad presents these non-GAAP financial measures because it believes that they are a useful indicator of its performance and on-going operations. The Company believes that these non-GAAP financial measures are useful to investors in part because such measures are frequently used by securities analysts to measure a company's operating performance without regard to certain items, such as income tax expense, net interest income and depreciation and amortization, which can vary substantially from company to company. vRad's management also uses these non-GAAP financial measures in order to review and assess its operating performance and its management team in connection with certain incentive programs and the preparation of its financial projections.

Adjusted EBITDA, adjusted net income and adjusted diluted earnings per share are not measurements of the Company's financial performance under GAAP and may not be comparable to the calculation of similarly titled measures reported by other companies. These measures should not be considered as an alternative to net income, earnings per share or any other performance measures derived in accordance with GAAP.

SOURCE: Virtual Radiologic Corporation

Virtual Radiologic Corporation
Mollie O'Brien, 952-595-1196
Director, Investor and Public Relations
mollie.obrien@vrad.com
http://www.vrad.com